Search

everythinglearnresearchcommunity

for

Search:↓

Rupert Raj supported trans individuals by sharing vital information and resources, boosting their confidence and security.

Transgender youth on hormone therapy need personalized acne treatments and supportive care.

The document concludes that individualized Facial Feminization Surgery plans and comprehensive care are crucial for successful outcomes.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

Lip feminization is important for transgender women, requiring personalized approaches and expert consultation for best results.

Facial feminization surgery is effective in helping transgender women appear more feminine and has high patient satisfaction.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Orthognathic surgeons play a key role in modifying masculine facial features to be more feminine, often improving transgender women's quality of life.

Facial gender surgery techniques focus on forehead and hairline changes for accurate results.

The conclusion is that certain surgeries can help people with gender dysphoria look more like their true gender and feel better.

There is unequal access to gender-affirming surgeries in Canada, with a need for better coverage and specialized programs.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Facial Feminization Surgery is effective and safe, with minimal complications.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Understanding sex and gender differences can improve personalized dermatology care.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Dermatologists should address discrimination and consider ethnic and gender differences in treatments.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Male pattern baldness is not a risk factor for heart disease based on cholesterol levels alone.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Testosterone treatment in transgender teens can worsen acne, requiring careful treatment due to mental health and medication side effects.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Transgender patients face more barriers to oral healthcare, leading to poorer oral health and quality of life.

The US Military supports transgender health care, but many needed skin procedures aren't covered by insurance.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.